Ryan K. Zeidan
California Institute of Technology
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ryan K. Zeidan.
Proceedings of the National Academy of Sciences of the United States of America | 2007
Jeremy D. Heidel; Zhongping Yu; Joanna Yi-Ching Liu; Yongchao Liang; Ryan K. Zeidan; Douglas J. Kornbrust; Mark E. Davis
The results of administering escalating, i.v. doses of targeted nanoparticles containing a siRNA targeting the M2 subunit of ribonucleotide reductase to non-human primates are reported. The nanoparticles consist of a synthetic delivery system that uses a linear, cyclodextrin-containing polycation, transferrin (Tf) protein targeting ligand, and siRNA. When administered to cynomolgus monkeys at doses of 3 and 9 mg siRNA/kg, the nanoparticles are well tolerated. At 27 mg siRNA/kg, elevated levels of blood urea nitrogen and creatinine are observed that are indicative of kidney toxicity. Mild elevations in alanine amino transferase and aspartate transaminase at this dose level indicate that the liver is also affected to some extent. Analysis of complement factors does not reveal any changes that are clearly attributable to dosing with the nanoparticle formulation. Detection of increased IL-6 levels in all animals at 27 mg siRNA/kg and increased IFN-γ in one animal indicate that this high dose level produces a mild immune response. Overall, no clinical signs of toxicity clearly attributable to treatment are observed. The multiple administrations spanning a period of 17–18 days enable assessment of antibody formation against the human Tf component of the formulation. Low titers of anti-Tf antibodies are detected, but this response is not associated with any manifestations of a hypersensitivity reaction upon readministration of the targeted nanoparticle. Taken together, the data presented show that multiple, systemic doses of targeted nanoparticles containing nonchemically modified siRNA can safely be administered to non-human primates.
Tetrahedron Letters | 2003
Jeremy A. May; Ryan K. Zeidan; Brian M. Stoltz
The development of an approach to the alkaloid communesin B (2) is presented. The approach is based on considerations of a possible biosynthetic sequence involving an oxidative coupling of tryptamine with a derivative of the ergot alkaloid aurantioclavine. Structure revision is also suggested for the recently isolated microfilament disrupting alkaloid nomofungin.
Journal of the American Chemical Society | 2008
Eric L. Margelefsky; Anissa Bendjeriou; Ryan K. Zeidan; Véronique Dufaud; Mark E. Davis
Ordered mesoporous silicas functionalized with alkylsulfonic acid and thiol group pairs have been shown to catalyze the synthesis of bisphenols from the condensation of phenol and various ketones, with activity and selectivity highly dependent on the distance between the acid and thiol. Here, a new route to thiol/sulfonic acid paired catalysts is reported. A bis-silane precursor molecule containing both a disulfide and a sulfonate ester bond is grafted onto the surface of ordered mesoporous silica, SBA-15, followed by simultaneous disulfide reduction and sulfonate ester hydrolysis. The resulting catalyst, containing organized pairs of arylsulfonic acid and thiol groups, is significantly more active than the alkylsulfonic acid/thiol paired catalyst in the synthesis of bisphenol A and Z, and this increase in activity does not lead to a loss of regioselectivity. The paired catalyst has activity similar to that of a randomly bifunctionalized arylsulfonic acid/thiol catalyst in the bisphenol A reaction but exhibits greater activity and selectivity than the randomly bifunctionalized catalyst in the bisphenol Z reaction.
Archive | 2010
Eric L. Margelefsky; Ryan K. Zeidan; Mark E. Davis
Enzymes catalyze reactions with high rates and selectivities through the sophisticated use of cooperative interactions between neighboring functional groups within an active site. For example, the “catalytic triad” in proteases is capable of accelerating the cleavage of amides by 1011 through neighboring interactions between carboxylic acid, imidazole, and alcohol sites. Guided by these principles, heterogeneous catalysts having two different types of functional groups have been prepared, and the cooperative behavior have been demonstrated with catalytic reactions in the liquid phase. Cooperative interactions between thiols and sulfonic acids and between incompatible acid and base groups are achievable with rates and selectivities that are superior to homogeneous systems, especially for the latter case wherein there is no reactivity.
Chemical Society Reviews | 2008
Eric L. Margelefsky; Ryan K. Zeidan; Mark E. Davis
Angewandte Chemie | 2006
Ryan K. Zeidan; Son-Jong Hwang; Mark E. Davis
Journal of Catalysis | 2007
Ryan K. Zeidan; Mark E. Davis
Journal of Medicinal Chemistry | 2006
Jianjun Cheng; Ryan K. Zeidan; Swaroop Mishra; Aijie Liu; Suzie H. Pun; Rajan P. Kulkarni; Gregory S. Jensen; Nathalie C. Bellocq; Mark E. Davis
Journal of Catalysis | 2006
Ryan K. Zeidan; Véronique Dufaud; Mark E. Davis
Journal of the American Chemical Society | 2007
Eric L. Margelefsky; Ryan K. Zeidan; Véronique Dufaud; Mark E. Davis